About this FactMed analysis covering adverse side effect reports of GLUCOPHAGE patients who developed ACHLORHYDRIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking GLUCOPHAGE reported ACHLORHYDRIA to the FDA. A total of 25198 GLUCOPHAGE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between GLUCOPHAGE and ACHLORHYDRIA. In doing so, we compare GLUCOPHAGE with other drugs that cause ACHLORHYDRIA, to help you evaluate whether or not GLUCOPHAGE causes ACHLORHYDRIA. Likewise, this page shows the most highly-reported side effects of GLUCOPHAGE, so you can see if ACHLORHYDRIA ranks among GLUCOPHAGE's most well-known side effects.
Summary Statistics
Reports of GLUCOPHAGE causing ACHLORHYDRIA: 3
Reports of any side effect of GLUCOPHAGE : 25198
Percentage of GLUCOPHAGE patients where ACHLORHYDRIA is a reported side effect: 0.0119%

FDA reports of any drug causing ACHLORHYDRIA : 27
Average percentage for all medicated patients where ACHLORHYDRIA is reported as a complication: 0.0002%

Physician opinion on GLUCOPHAGE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing GLUCOPHAGE:
DIABETES MELLITUS ( 2914 patients )
TYPE 2 DIABETES MELLITUS ( 1195 patients )
DIABETES MELLITUS NON-INSULIN-DEPENDENT ( 467 patients )
DRUG USE FOR UNKNOWN INDICATION ( 451 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 367 patients )
POLYCYSTIC OVARIES ( 94 patients )
INSULIN RESISTANCE ( 44 patients )
GLUCOSE TOLERANCE IMPAIRED ( 38 patients )
BLOOD GLUCOSE INCREASED ( 25 patients )
TYPE 1 DIABETES MELLITUS ( 23 patients )
ILL-DEFINED DISORDER ( 22 patients )
INSULIN-REQUIRING TYPE II DIABETES MELLITUS ( 20 patients )
INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS ( 19 patients )
DIABETES MELLITUS INSULIN-DEPENDENT ( 16 patients )
BLOOD GLUCOSE ABNORMAL ( 15 patients )
HYPERGLYCAEMIA ( 11 patients )
BLOOD GLUCOSE ( 10 patients )
DIABETES MELLITUS MANAGEMENT ( 10 patients )
WEIGHT DECREASED ( 9 patients )
DIABETES MELLITUS INADEQUATE CONTROL ( 8 patients )
INTENTIONAL OVERDOSE ( 7 patients )
METABOLIC SYNDROME ( 7 patients )
PROPHYLAXIS ( 5 patients )
GESTATIONAL DIABETES ( 5 patients )
INSULIN RESISTANCE SYNDROME ( 5 patients )
UNEVALUABLE EVENT ( 4 patients )
HORMONE REPLACEMENT THERAPY ( 4 patients )
OVARIAN CYST ( 4 patients )
HYPERINSULINAEMIA ( 4 patients )
INFERTILITY ( 4 patients )
ENDOMETRIOSIS ( 3 patients )
APPETITE DISORDER ( 3 patients )
OBESITY ( 3 patients )
PROSTATIC OPERATION ( 3 patients )
ANTIDIURETIC HORMONE ABNORMALITY ( 3 patients )
BLOOD ANTIDIURETIC HORMONE DECREASED ( 3 patients )
HYPERTENSION ( 3 patients )
BLOOD GLUCOSE FLUCTUATION ( 3 patients )
BLOOD INSULIN INCREASED ( 2 patients )
INSULIN RESISTANT DIABETES ( 2 patients )
GLUCOSE TOLERANCE TEST ABNORMAL ( 2 patients )
MENSTRUATION IRREGULAR ( 2 patients )
PANCREATIC CARCINOMA METASTATIC ( 2 patients )
DIABETIC VASCULAR DISORDER ( 2 patients )
WEIGHT CONTROL ( 2 patients )
BLOOD DISORDER ( 2 patients )
PAIN ( 2 patients )
RENAL FAILURE ( 1 patients )
GLUCOSE TOLERANCE DECREASED ( 1 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 1 patients )
DEPRESSION ( 1 patients )
ACUTE CORONARY SYNDROME ( 1 patients )
GOUT ( 1 patients )
BLOOD CHOLESTEROL INCREASED ( 1 patients )
OVERDOSE ( 1 patients )
HYPERINSULINISM ( 1 patients )
BLOOD GLUCOSE DECREASED ( 1 patients )
INFERTILITY FEMALE ( 1 patients )
BLOOD TRIGLYCERIDES INCREASED ( 1 patients )
THYROID DISORDER ( 1 patients )
DEMENTIA ALZHEIMER'S TYPE ( 1 patients )
ACCIDENTAL EXPOSURE ( 1 patients )
GLYCOSYLATED HAEMOGLOBIN INCREASED ( 1 patients )
DIABETES INSIPIDUS ( 1 patients )
HEPATITIS CHOLESTATIC ( 1 patients )
HORMONE THERAPY ( 1 patients )
DIABETES PROPHYLAXIS ( 1 patients )
DRUG EXPOSURE DURING PREGNANCY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ACHLORHYDRIA:

ASPIRIN (8 patients)
AMLODIPINE (7 patients)
COREG (6 patients)
COUMADIN (6 patients)
FLUCONAZOLE (6 patients)
GLUCOVANCE (6 patients)
GLYBURIDE (6 patients)
LASIX (6 patients)
LEVAQUIN (6 patients)
LIPITOR (6 patients)
PROMETHAZINE (6 patients)
SEROQUEL (6 patients)
AMOXICILLIN (5 patients)
CARVEDILOL (5 patients)
CIPROFLOXACIN (5 patients)
CYANOCOBALAMIN (5 patients)
DIGOXIN (5 patients)
DOXYCYCLINE (5 patients)
FOSINOPRIL SODIUM (5 patients)
GABAPENTIN (5 patients)
LISINOPRIL (5 patients)
LORCET-HD (5 patients)
MELOXICAM (5 patients)
METOLAZONE (5 patients)
NEXIUM (5 patients)
OMEPRAZOLE (5 patients)
OXYCODONE HCL AND ACETAMINOPHEN (5 patients)
ACULAR (4 patients)
GEMFIBROZIL (4 patients)
MUPIROCIN OINTMENT (4 patients)
NEORAL (4 patients)
POTASSIUM CHLORIDE (4 patients)
SILVASORB (4 patients)
TEMAZEPAM (4 patients)
TRIMETHO SULFAMETHOX (4 patients)
ACTOS (3 patients)
AGGRENOX (3 patients)
GLUCOPHAGE (3 patients)
KLOR-CON (3 patients)
LANSOPRAZOLE (3 patients)
SODIUM BICARBONATE (3 patients)
CODEINE (2 patients)
COZAAR (2 patients)
FUROSEMIDE (2 patients)
HYDROCODONE (2 patients)
MUPIROCIN (2 patients)
PANTOPRAZOLE SODIUM (2 patients)
PEG (2 patients)
POTASSIUM (2 patients)
PRILOSEC OTC (2 patients)
PROPO-K (2 patients)
RANITIDINE (2 patients)
SIMVASTATIN (2 patients)
SPIRIVA (2 patients)
SULFAMETHOXAZOLE AND TRIMETHOPRIM (2 patients)
WARFARIN SODIUM (2 patients)
ZANTAC (2 patients)
ACETYLSALICYLIC ACID SRT (1 patients)
ADVAIR HFA (1 patients)
ALBUTEROL SULFATE AUTOHALER (1 patients)
ALCOHOL (1 patients)
ALLEGRA (1 patients)
AMOXICILLIN+CLAVULANATE (1 patients)
ATENOLOL (1 patients)
AZITHROMYCIN (1 patients)
BUPROPION HCL (1 patients)
CALCIUM SUPPLEMENTS (1 patients)
CHLORTHALIDONE (1 patients)
CLOFAZIMINE (1 patients)
CLONAZEPAM (1 patients)
CLOTRIMAZOLE (1 patients)
COCAINE (1 patients)
COMBIVENT (1 patients)
CORTICOSTEROIDS (1 patients)
CYCLOBENZAPRINE (1 patients)
DARVOCET-N 100 (1 patients)
DEPO-MEDROL (1 patients)
DIET (NO INGREDIENTS/SUBSTANCES) (1 patients)
DIFLUCAN (1 patients)
DUONEB (1 patients)
EFFEXOR (1 patients)
ETHAMBUTOL HYDROCHLORIDE (1 patients)
FERROUS GLUCONATE (1 patients)
FLONASO (1 patients)
FLOR-CON (1 patients)
FLOVENT (1 patients)
INSULIN (1 patients)
LACTAID (1 patients)
LITHIUM CARBONATE (1 patients)
LOVASTATIN (1 patients)
MIRAPEX (1 patients)
MONTELUKAST SODIUM (1 patients)
NEOSTIGMINE BROMIDE (1 patients)
PAROXETINE HCL (1 patients)
PEPCID (1 patients)
POTASSIUM CHLORIDE CR (1 patients)
PRAVACHOL (1 patients)
PREDNISONE (1 patients)
PREMARIN (1 patients)
PREVACID (1 patients)
PRILOSEC (1 patients)
QUINIDINE GLUCONATE (1 patients)
RANITIDINE 150MG TABLETS, UNKNOWN MANUFACTURER (1 patients)
RANITIDINE HCL (1 patients)
RANITIDINE HYDROCHLORIDE (1 patients)
RECLAST (1 patients)
ROPINIROLE (1 patients)
SINGULAIR (1 patients)
SODIUM BICARBONATE IN PLASTIC CONTAINER (1 patients)
SYNTHROID (1 patients)
TOPROL-XL (1 patients)
TRAZODONE HCL (1 patients)
TRILEPTAL (1 patients)
TRIMEBUTINE (1 patients)
ZETIA (1 patients)
Most common side effects for patients taking GLUCOPHAGE:
BLOOD GLUCOSE INCREASED (3192 patients)
NAUSEA (3041 patients)
WEIGHT DECREASED (2413 patients)
MYOCARDIAL INFARCTION (2071 patients)
DIARRHOEA (1645 patients)
VOMITING (1575 patients)
CARDIAC FAILURE CONGESTIVE (1500 patients)
DYSPNOEA (1413 patients)
DIZZINESS (1271 patients)
PAIN (1260 patients)
CHEST PAIN (1208 patients)
DECREASED APPETITE (1198 patients)
FATIGUE (1194 patients)
ASTHENIA (1150 patients)
CEREBROVASCULAR ACCIDENT (1139 patients)
BLOOD GLUCOSE DECREASED (1135 patients)
CORONARY ARTERY DISEASE (1087 patients)
ANXIETY (1068 patients)
HEADACHE (1063 patients)
RENAL FAILURE ACUTE (1053 patients)
DRUG INEFFECTIVE (1052 patients)
HYPERTENSION (957 patients)
DIABETES MELLITUS (952 patients)
DEPRESSION (894 patients)
FALL (879 patients)
OEDEMA PERIPHERAL (864 patients)
WEIGHT INCREASED (850 patients)
RENAL FAILURE (797 patients)
ANAEMIA (792 patients)
BACK PAIN (759 patients)
HYPOGLYCAEMIA (708 patients)
INJURY (701 patients)
ABDOMINAL PAIN (655 patients)
PAIN IN EXTREMITY (655 patients)
DEHYDRATION (641 patients)
ARTHRALGIA (625 patients)
PNEUMONIA (603 patients)
CONSTIPATION (584 patients)
ABDOMINAL PAIN UPPER (575 patients)
ATRIAL FIBRILLATION (570 patients)
MALAISE (566 patients)
INSOMNIA (562 patients)
CARDIAC DISORDER (542 patients)
DEATH (535 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (534 patients)
PYREXIA (528 patients)
HYPERHIDROSIS (527 patients)
LACTIC ACIDOSIS (523 patients)
COUGH (522 patients)
URINARY TRACT INFECTION (516 patients)
DYSPEPSIA (510 patients)
DIABETES MELLITUS INADEQUATE CONTROL (502 patients)
TREMOR (477 patients)
TYPE 2 DIABETES MELLITUS (453 patients)
PANCREATITIS (451 patients)
CONFUSIONAL STATE (446 patients)
FEELING ABNORMAL (440 patients)
HYPOTENSION (427 patients)
HYPOAESTHESIA (415 patients)
MYALGIA (393 patients)
HYPERKALAEMIA (393 patients)
EMOTIONAL DISTRESS (392 patients)
PRURITUS (389 patients)
VISION BLURRED (388 patients)
SOMNOLENCE (388 patients)
ABDOMINAL DISTENSION (387 patients)
RASH (383 patients)
PALPITATIONS (382 patients)
BLOOD PRESSURE INCREASED (382 patients)
TRANSIENT ISCHAEMIC ATTACK (377 patients)
DRUG INTERACTION (377 patients)
MUSCLE SPASMS (368 patients)
HYPERGLYCAEMIA (364 patients)
CONDITION AGGRAVATED (355 patients)
ANOREXIA (348 patients)
CARDIOMEGALY (342 patients)
LOSS OF CONSCIOUSNESS (341 patients)
INJECTION SITE PAIN (340 patients)
CHOLELITHIASIS (339 patients)
HYPERLIPIDAEMIA (337 patients)
BLOOD CHOLESTEROL INCREASED (333 patients)
NEUROPATHY PERIPHERAL (323 patients)
ANGINA PECTORIS (321 patients)
DRUG EFFECT DECREASED (315 patients)
CHEST DISCOMFORT (309 patients)
SYNCOPE (308 patients)
MUSCULAR WEAKNESS (302 patients)
CONVULSION (300 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (293 patients)
BRONCHITIS (290 patients)
GLYCOSYLATED HAEMOGLOBIN INCREASED (286 patients)
PULMONARY EMBOLISM (285 patients)
PARAESTHESIA (285 patients)
PLEURAL EFFUSION (283 patients)
DEEP VEIN THROMBOSIS (280 patients)
INJECTION SITE BRUISING (275 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (273 patients)
SINUSITIS (271 patients)
SLEEP APNOEA SYNDROME (268 patients)
THROMBOCYTOPENIA (267 patients)
MYOCARDIAL ISCHAEMIA (265 patients)
CONTUSION (261 patients)
ACUTE MYOCARDIAL INFARCTION (261 patients)
STRESS (260 patients)
OSTEOARTHRITIS (258 patients)
CELLULITIS (256 patients)
DYSPHAGIA (255 patients)
OEDEMA (254 patients)
HEPATIC STEATOSIS (254 patients)
BLOOD CREATININE INCREASED (253 patients)
GAIT DISTURBANCE (253 patients)
CARDIAC ARREST (252 patients)
DIABETIC NEUROPATHY (248 patients)
ANGINA UNSTABLE (247 patients)
INJECTION SITE HAEMORRHAGE (245 patients)
ANHEDONIA (244 patients)
MITRAL VALVE INCOMPETENCE (243 patients)
CHILLS (242 patients)
MEDICATION ERROR (241 patients)
FLATULENCE (241 patients)
CARDIOVASCULAR DISORDER (241 patients)
METABOLIC ACIDOSIS (234 patients)
ASTHMA (232 patients)
OVERDOSE (230 patients)
ERYTHEMA (227 patients)
HEART RATE INCREASED (224 patients)
FLUSHING (222 patients)
CARDIAC FAILURE (219 patients)
PANCREATITIS ACUTE (217 patients)
PULMONARY OEDEMA (216 patients)
CARDIOMYOPATHY (216 patients)
HYPONATRAEMIA (216 patients)
TACHYCARDIA (214 patients)
ECONOMIC PROBLEM (213 patients)
DYSGEUSIA (212 patients)
RESPIRATORY FAILURE (212 patients)
OSTEOMYELITIS (212 patients)
ARTERIOSCLEROSIS (212 patients)
UNEVALUABLE EVENT (211 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (210 patients)
FLUID RETENTION (209 patients)
HAEMOGLOBIN DECREASED (208 patients)
HEART INJURY (207 patients)
ARTHRITIS (207 patients)
RENAL IMPAIRMENT (202 patients)
BLOOD GLUCOSE FLUCTUATION (200 patients)
NASOPHARYNGITIS (199 patients)
ARRHYTHMIA (199 patients)
THROMBOSIS (198 patients)
CORONARY ARTERY OCCLUSION (194 patients)
NERVOUSNESS (193 patients)
GASTRITIS (191 patients)
SWELLING (191 patients)
URTICARIA (190 patients)
SEPSIS (190 patients)
BRADYCARDIA (189 patients)
CATARACT (188 patients)
GASTROINTESTINAL HAEMORRHAGE (187 patients)
HYPERSENSITIVITY (187 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (185 patients)
NEPHROLITHIASIS (183 patients)
INCORRECT DOSE ADMINISTERED (183 patients)
ALANINE AMINOTRANSFERASE INCREASED (183 patients)
CARPAL TUNNEL SYNDROME (183 patients)
HYPERCHOLESTEROLAEMIA (180 patients)
PULMONARY HYPERTENSION (179 patients)
ABDOMINAL DISCOMFORT (178 patients)
FEAR (178 patients)
ISCHAEMIC CARDIOMYOPATHY (177 patients)
DYSPNOEA EXERTIONAL (176 patients)
VERTIGO (176 patients)
ERUCTATION (174 patients)
BLOOD TRIGLYCERIDES INCREASED (174 patients)
TRICUSPID VALVE INCOMPETENCE (173 patients)
FEELING JITTERY (173 patients)
SUICIDAL IDEATION (172 patients)
MEMORY IMPAIRMENT (170 patients)
BALANCE DISORDER (170 patients)
RENAL FAILURE CHRONIC (169 patients)
ARTHROPATHY (167 patients)
UPPER RESPIRATORY TRACT INFECTION (166 patients)
NECK PAIN (166 patients)
OBESITY (165 patients)
OSTEONECROSIS OF JAW (165 patients)
AMNESIA (164 patients)
HYPOKALAEMIA (163 patients)
VISUAL ACUITY REDUCED (162 patients)
ADVERSE EVENT (158 patients)
INTERVERTEBRAL DISC DEGENERATION (156 patients)
ATELECTASIS (156 patients)
ROAD TRAFFIC ACCIDENT (155 patients)
STAPHYLOCOCCAL INFECTION (155 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (155 patients)
DIABETIC KETOACIDOSIS (153 patients)
CARDIO-RESPIRATORY ARREST (152 patients)
MULTI-ORGAN FAILURE (152 patients)
OSTEONECROSIS (152 patients)
BLOOD UREA INCREASED (151 patients)
STOMACH DISCOMFORT (151 patients)
POLLAKIURIA (149 patients)
EPISTAXIS (148 patients)
DRY MOUTH (146 patients)
MUSCULOSKELETAL PAIN (144 patients)
JOINT SWELLING (144 patients)
RHABDOMYOLYSIS (142 patients)
HEPATITIS (142 patients)
DYSURIA (142 patients)
COMA (142 patients)
RENAL DISORDER (142 patients)
DIABETIC RETINOPATHY (141 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for GLUCOPHAGE


Issue Description / Topic Timestamp
QUESTION
LYMPHADENOPATHY
Imhave altace 1.25 mg, metformin 2000 mg by day, i have 44 years old, i have 2 lymphopathy at axillair for 6 months very painful. I got echo of breast said benign like, but very dense breast. I do not have BCRA1-2 gene. I got MRI with contrast last week. Please my Question: If MRI is said "normal", is it more safe to do mastectomy (ex with mayo clinic journals and other md journals? ) 2015-06-12 21:20:13
QUESTION
HYPERHIDROSIS
Is hyperhidrosis one of the side effects of glucophage xr 2016-04-18 13:04:05
QUESTION
ECZEMA
I have recently been diagnosed with Type 2 Diabetes and am taking 2x500g Glucophage per day. After two weeks I have suddenly developed a rash on my chest , head and legs. Is this a side effect ? 2016-04-20 08:05:26
QUESTION
INTENTIONAL OVERDOSE
I was incredibly pleased to discover this web-site.I wanted to thank you for this really good read I untulbdedoy enjoying each small bit of it and I have you bookmarked to take a look at new stuff you put up. 2017-03-20 09:07:32

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ACHLORHYDRIA and GLUCOPHAGE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking GLUCOPHAGE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in GLUCOPHAGE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for GLUCOPHAGE experts. If you are a healthcare provider experienced in prescribing GLUCOPHAGE, please register here.
giCould not connect: